Archive for the Category ◊ Biologics ◊

• Wednesday, January 29th, 2014

Mountain View, Calif. –January 28, 2014 23andMe, the leading personal genetics company, has participated in the first ever genome-wide association study of the combined asthma-with-hay fever phenotype. Led by researchers at the QIMR Berghofer Medical Research Institute, the study identified 11 independent genetic markers associated with the development of asthma-with-hay fever, including two associations reaching […]

• Wednesday, December 04th, 2013

Teleflex Completes Previously Announced Acquisition of Vidacare Corporation LIMERICK, Pa.–(BUSINESS WIRE)– Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, announced today that it has completed the previously announced acquisition of Vidacare Corporation, the leading provider of intraosseous, or inside the bone, access devices. Based on the date of […]

• Thursday, November 14th, 2013

ENGINEERING COMPANY BCD announced the creation of 40 new jobs resulting from a new multi-million euro vaccine plant project in the Asian market. The north Cork company celebrated 30 years in business this year and currently employs 190 staff. The jobs will be a mix of engineering and trades roles in the company’s design and […]

• Tuesday, October 22nd, 2013

LAKEWOOD, Colo.–(BUSINESS WIRE)–Terumo BCT has been awarded a U.S. Department of Defense (DoD) cost-share contract worth up to $29.9M to advance the Mirasol System for the treatment of donated whole blood used in emergency transfusions in deployed military forces. KEY FACTS: * Terumo BCT is working with the U.S. Army Medical Research and Materiel Command […]

• Wednesday, October 16th, 2013

Johnson & Johnson has traditionally had a strong medical device and diagnostics sectors but the growth in both of those areas has slowed. In the second quarter of 2013, the device segment grew at a rate of 0.5%—ignoring the Synthes acquisition and currency fluctuations. The company is rumored to be mulling the sale of its […]

• Tuesday, September 24th, 2013

Medtronic asks a federal judge in Arizona to reconsider a ruling that kept a lawsuit over its Infuse bone-growth protein alive. Medtronic (NYSE:MDT) wants a federal judge in Arizona to reconsider his decision not to dismiss a lawsuit filed over its Infuse bone-growth protein. Fridley, Minn.-based Medtronic had asked Judge G. Murray Snow of the […]

• Wednesday, August 28th, 2013

Tissue Regeneration Systems Receives 510K Approval ANN ARBOR, Mich., Aug. 26, 2013 /PRNewswire/ — Tissue Regeneration Systems, Inc. (“TRS”) today announced that it has received 510K approval from the U.S. Food and Drug Administration for its Cranial Bone Void Filler product, indicated for use in the repair of neurosurgical burr holes. This is first of a family […]

• Thursday, August 22nd, 2013

Researchers at the Institute of Bioengineering and Nanotechnology (IBN) have developed a simple method of organizing cells and their microenvironments in hydrogel fibers. Their unique technology provides a feasible template for assembling complex structures, such as liver and fat tissues, as described in their recent publication in Nature Communications. According to IBN Executive Director Professor Jackie […]

• Thursday, August 15th, 2013

(CNN) — U.S. researchers reported a breakthrough Thursday in the search for a vaccine for malaria, the mosquito-borne disease that sickens millions worldwide. More than three dozen volunteers received multiple, intravenous doses of a vaccine produced with a weakened form of the disease, scientists from the National Institutes of Health, the Navy, Army and other organizations reported […]

• Thursday, July 25th, 2013

The search for new drugs, including those for cancer, is set to speed up thanks to a new research technique invented by scientists at the Nanyang Technological University (NTU). Named the “Cellular Thermal Shift Assay” (CETSA), scientists can now know for sure if a drug had reached its target protein in the body, which is a […]